Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade).
Hoskins, P.J.
Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade). [electronic resource] - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Mar 1995 - 134-142 p. digital
Publication Type: Journal Article
1525-1438
10.1046/j.1525-1438.1995.05020134.x doi
Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade). [electronic resource] - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Mar 1995 - 134-142 p. digital
Publication Type: Journal Article
1525-1438
10.1046/j.1525-1438.1995.05020134.x doi